相关实验视频
Updated: Jul 11, 2026
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
21.9K
在亚重型肺栓塞中使用太尼克特等离子体导向的血栓缓解疗法:一个病例报告
Dania Ghaziri1, Hisham Bou Fakhreddine2, Fadi Sawaya2
1Department of Pharmacy American University of Beirut Medical Center, Beirut, Lebanon.
Case reports in critical care
|August 29, 2024
概括
这项研究引入了在肺栓塞 (PE) 病例中用于导管导向血栓溶解 (CDT) 的基酶. 在高风险PE中,当Alteplase无法使用时,Tenecteplase CDT被证明是安全和有效的.
科学领域:
- 心脏病学 心脏病学
- 血管医学 血管医学
- 干预性放射学 干预性放射学
背景情况:
- 肺栓塞 (PE) 治疗往往涉及以导管导向的血栓溶解 (CDT) 与 alteplase.
- 由于经济因素,常见的血栓溶解剂阿尔特拉面临着不可用性.
- 通常用于静脉注射的 Tenecteplase 被认为是CDT的替代品.
研究的目的:
- 描述在患有急性中期高风险PE的患者中使用tenecteplase用于CDT的初始经验.
- 在这种特定的临床场景中评估tenecteplase的安全性和有效性.
- 为了评估患者在基酶引导的CDT期间和之后的结果.
主要方法:
- 一名73岁的男性中期高风险PE接受了CDT.
- 丁氏甲被用0.5毫克/小时,持续30小时 (共15毫克),同时注入肝素.
- 下肢双重证实了股骨和骨静脉血栓形成.
主要成果:
- 经过24小时的特内克酶启动后,呼吸障碍和生命体征显著改善.
- 氧气支持被断绝了.
- 发生了一种轻微的,可控的部接入部位出血并发症,不需要输血或停止服用肝素.
结论:
- 通过导管导向的血栓溶解与丁氏甲是一种安全有效的替代方案,用于中期高风险PE,当丁氏甲是不可用的.
- 基酶CDT和治疗性肝素输注的组合被很好地容忍.
- 需要进一步的研究来证实这些发现,并确定tenecteplase在PE的CDT中的作用.
相关概念视频
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...